5,384 Shares in CVS Health Corporation $CVS Purchased by Kera Capital Partners Inc.

Key Points

• Kera Capital Partners Inc. acquired 5,384 shares of CVS Health Corporation, valued at approximately $371,000, in the second quarter.
• CVS Health reported $1.81 earnings per share for the recent quarter, exceeding expectations and achieving 8.4% revenue growth year-over-year.
• The company declared a quarterly dividend of $0.665, representing a 3.5% dividend yield, with a payout ratio of 74.30%.

Kera Capital Partners Inc. bought a new position in shares of CVS Health Corporation (NYSE:CVS - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 5,384 shares of the pharmacy operator's stock, valued at approximately $371,000.

A number of other large investors also recently bought and sold shares of CVS. Essex Financial Services Inc. boosted its holdings in CVS Health by 0.8% during the first quarter. Essex Financial Services Inc. now owns 20,705 shares of the pharmacy operator's stock worth $1,403,000 after buying an additional 166 shares in the last quarter. Hemington Wealth Management grew its holdings in CVS Health by 33.7% in the first quarter. Hemington Wealth Management now owns 682 shares of the pharmacy operator's stock valued at $46,000 after purchasing an additional 172 shares during the period. McIlrath & Eck LLC raised its stake in shares of CVS Health by 32.6% during the 4th quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator's stock worth $32,000 after buying an additional 174 shares during the period. Sumitomo Life Insurance Co. increased its holdings in CVS Health by 1.0% in the 1st quarter. Sumitomo Life Insurance Co. now owns 17,114 shares of the pharmacy operator's stock worth $1,159,000 after acquiring an additional 174 shares in the last quarter. Finally, Koshinski Asset Management Inc. lifted its holdings in CVS Health by 3.7% during the first quarter. Koshinski Asset Management Inc. now owns 4,930 shares of the pharmacy operator's stock valued at $334,000 after purchasing an additional 178 shares in the last quarter. 80.66% of the stock is owned by institutional investors and hedge funds.

CVS Health Stock Performance

Shares of CVS Health stock opened at $75.00 on Friday. The firm has a market cap of $95.12 billion, a PE ratio of 20.95, a price-to-earnings-growth ratio of 0.82 and a beta of 0.62. CVS Health Corporation has a 52 week low of $43.56 and a 52 week high of $75.55. The business's fifty day simple moving average is $67.11 and its 200-day simple moving average is $66.32. The company has a quick ratio of 0.62, a current ratio of 0.80 and a debt-to-equity ratio of 0.74.

CVS Health (NYSE:CVS - Get Free Report) last announced its earnings results on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share for the quarter, topping the consensus estimate of $1.46 by $0.35. CVS Health had a net margin of 1.17% and a return on equity of 10.51%. The company had revenue of $98.92 billion during the quarter, compared to analyst estimates of $94.87 billion. During the same quarter last year, the firm posted $1.83 earnings per share. CVS Health's revenue was up 8.4% compared to the same quarter last year. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. Equities analysts forecast that CVS Health Corporation will post 5.89 earnings per share for the current year.

CVS Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, August 1st. Investors of record on Tuesday, July 22nd were issued a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 3.5%. The ex-dividend date was Tuesday, July 22nd. CVS Health's payout ratio is currently 74.30%.

Insider Transactions at CVS Health

In related news, Director Anne A. Finucane sold 7,500 shares of the firm's stock in a transaction dated Wednesday, August 20th. The stock was sold at an average price of $71.02, for a total transaction of $532,650.00. Following the completion of the transaction, the director directly owned 22,156 shares in the company, valued at $1,573,519.12. This trade represents a 25.29% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Insiders own 1.22% of the company's stock.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on CVS shares. Zacks Research downgraded CVS Health from a "strong-buy" rating to a "hold" rating in a research report on Monday, September 8th. Bernstein Bank decreased their price target on shares of CVS Health from $78.00 to $72.00 and set a "market perform" rating on the stock in a research note on Wednesday, July 16th. UBS Group raised shares of CVS Health from a "neutral" rating to a "buy" rating and upped their price objective for the company from $67.00 to $79.00 in a research note on Monday, August 18th. Baird R W upgraded CVS Health from a "hold" rating to a "strong-buy" rating in a report on Thursday, August 14th. Finally, Robert W. Baird raised CVS Health from a "neutral" rating to an "outperform" rating and increased their price target for the company from $71.00 to $82.00 in a report on Thursday, August 14th. Two research analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and three have assigned a Hold rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $77.89.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.